Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2021 ∙ Kuznetsova, L. Cortassa, G. Trilla, A.

Effectiveness of mandatory and incentive-based routine childhood immunization programs in europe: A systematic review of the literature

  • Europe
  • All age groups
  • COVID-19
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ McMillan, M. Chandrakumar, A. Wang, H. L. R. Clarke, M. Sullivan, T. R. Andrews, R. M. Ramsay, M. Marshall, H. S.

Effectiveness of Meningococcal Vaccines at Reducing Invasive Meningococcal Disease and Pharyngeal Neisseria meningitidis Carriage: A Systematic Review and Meta-analysis

  • All age groups
  • Meningococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2021 ∙ Coleman, B. L. Sanderson, R. Haag, M. D. M. McGovern, I.

Effectiveness of the MF59-adjuvanted trivalent or quadrivalent seasonal influenza vaccine among adults 65 years of age or older, a systematic review and meta-analysis

  • Older adults
  • Influenza
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Wang, Y. Li, J. Dai, P. Liu, P. Zhu, F.

Effectiveness of the oral human attenuated pentavalent rotavirus vaccine (RotaTeq™) postlicensure: a meta-analysis—2006–2020

  • Newborn
  • Children
  • Rotavirus
  • Efficacy/effectiveness
  • Administration
  • Coverage
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Cheng, C. J. Lu, C. Y. Chang, Y. H. Sun, Y. Chu, H. J. Lee, C. Y. Liu, C. H. Lin, C. H. Lu, C. J. Li, C. Y.

Effectiveness of the who-authorized covid-19 vaccines: A rapid review of global reports till 30 june 2021

  • Adolescents
  • Adults
  • Older adults
  • Healthcare workers
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Chen, D. Li, Y. Wu, Q.

Effectiveness of varicella vaccine as post-exposure prophylaxis: a meta-analysis

  • Children
  • Varicella
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Yedlapati, S. H. Khan, S. U. Talluri, S. Lone, A. N. Khan, M. Z. Khan, M. S. Navar, A. M. Gulati, M. Johnson, H. Baum, S. Michos, E. D.

Effects of Influenza Vaccine on Mortality and Cardiovascular Outcomes in Patients With Cardiovascular Disease: A Systematic Review and Meta-Analysis

  • Adults
  • Influenza
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Harder, T. Koch, J. Vygen-Bonnet, S. Külper-Schiek, W. Pilic, A. Reda, S. Scholz, S. Wichmann, O.

Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Low
2021 ∙ Lee, J. K. H. Lam, G. K. L. Shin, T. Samson, S. I. Greenberg, D. P. Chit, A.

Efficacy and effectiveness of high-dose influenza vaccine in older adults by circulating strain and antigenic match: An updated systematic review and meta-analysis

  • Older adults
  • Influenza
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Khan, M. Li, X. Yan, M. Li, Z. Yang, H. Liao, G.

Efficacy and safety of actively personalized neoantigen vaccination in the management of newly diagnosed glioblastoma: A systematic review

  • Adults
  • Older adults
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...